Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02439749 · ClinicalTrials.gov registry record · NA
SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 366
- Enrollment target
NCT02439749 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 366 participants.
The verdict
NCT02439749, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 366 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the absence of antihypertensive medications.
Interventions
- PROCEDURE Sham Procedure
- DEVICE Symplicity Spyral™ multi-electrode renal denervation system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 366 participants |
| Start Date | 2015-06 |
| Est. Completion | 2023-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02439749
The ClinicalTrials.gov registry entry for NCT02439749 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 366 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT02439749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02439749 about?
NCT02439749 is a clinical study titled "SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study". The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the absence of antihypertensive medications.
What is the current status of trial NCT02439749?
This trial is currently completed. It is a NA study. The enrollment target is 366 participants. The study started on 2015-06. Estimated completion is 2023-10-25.
What interventions are being tested in trial NCT02439749?
The interventions under investigation include: Sham Procedure (PROCEDURE), Symplicity Spyral™ multi-electrode renal denervation system (DEVICE).
Who is sponsoring clinical trial NCT02439749?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.